Jessica March, Senior Director of Marketing - Rare Disease
Professional Overview
Jessica March is a seasoned marketing executive with over 15 years of experience driving commercial success for pharmaceutical and biotech companies. As the Senior Director of Marketing - Rare Disease at Otsuka Pharmaceutical Companies (U.S.), she leverages her deep industry expertise to lead the strategic development and execution of impactful marketing campaigns for rare disease treatments.
Experience Summary
Current Role
As the Senior Director of Marketing - Rare Disease at Otsuka Pharmaceutical Companies (U.S.), Jessica is responsible for developing and implementing comprehensive marketing strategies to drive awareness, demand, and patient access for the company's rare disease portfolio. She oversees cross-functional teams to ensure seamless integration of marketing, access, and patient support initiatives, contributing to the commercial success of Otsuka's rare disease products.
Career Progression
Prior to her current role, Jessica held senior marketing and commercial operations positions at leading pharmaceutical and biotech organizations, including Amicus Therapeutics, Mallinckrodt Pharmaceuticals, DBV Technologies, and Celgene. Throughout her career, she has demonstrated a track record of driving successful product launches, optimizing marketing campaigns, and implementing innovative digital strategies to enhance patient engagement and market penetration.
Academic Background
Jessica holds a Bachelor of Science degree in Marketing from the University of Pennsylvania's Wharton School, where she graduated with distinction.
Areas of Expertise
- Rare disease marketing and commercialization
- Strategic marketing planning and execution
- Cross-functional team leadership and collaboration
- Digital marketing and patient engagement
- Market access and payer strategy development
- New product launch planning and implementation
Professional Impact
During her tenure at Amicus Therapeutics, Jessica played a pivotal role in the successful launch of a groundbreaking rare disease treatment, leading to a significant increase in patient enrollment and market share. At Mallinckrodt Pharmaceuticals, she spearheaded the development of a comprehensive digital marketing strategy that enhanced patient education and improved treatment adherence by 28%.
Conclusion
With her extensive experience in the rare disease sector and a proven track record of driving commercial success, Jessica March is a valuable asset to Otsuka Pharmaceutical Companies (U.S.). Her strategic vision, marketing expertise, and cross-functional leadership capabilities position her as a trusted advisor and strategic partner in the rare disease space.
